Howard Cooper Masuoka, MD
Gastroenterology · Batesville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Margaret Mary Community Hospital Inc · Iu Health Medical Group LLC
Looking this up.
Hospitals listed: Eskenazi Health · Indiana University Health · Margaret Mary Health. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Masuoka’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C184254 · Current
Licensed to practise in California · since 2023 · expires 2027-02-28 · University of Alabama School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Eskenazi HealthIndianapolis, INAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Eskenazi HealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Indiana University HealthIndianapolis, INAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Indiana University Health, which runs 14 hospitalsHome of Indiana University Melvin and Bren Simon Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 2 of 5 · 63% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.199, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.631, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.344, Oct 2024 – Sep 2025
- Margaret Mary Community Hospital IncBatesville, INCritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Margaret Mary HealthPatients rate it 4 of 5 · 69% would definitely recommend itNo overall ratingWorse than the national rate — Clostridium Difficile (C.Diff): 2.909, Oct 2024 – Sep 2025
See every measure and the patient survey for Eskenazi Health
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0 to 2.01) · 351 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.51 to 1.31) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 177.09 (121.56 to 232.61) · 46 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.6 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 109 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.6 · 87 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.8 · 126 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 1,251 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,353 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.49) · 2,407 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.02 (1.66 to 6.37) · 432 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.67 (0 to 3.4) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.7 to 3.92) · 424 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.94 (0 to 18.89) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.08 (1.77 to 10.39) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 65 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 1) · 2,062 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.286 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.213 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.261 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.92 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 69 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.3 · 340 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.4 · 135 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.1 · 83 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6 (3.8 to 9.3) · 39 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (6.9 to 14.3) · 39 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 288 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.3 to 17) · 344 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 49 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,788 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for Indiana University Health
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 8 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.199 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.631 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.344 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.38 (0.74 to 2.02) · 4,418 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.87 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 170.2 (138.94 to 201.46) · 355 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 76 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 136 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 325 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.1 · 457 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 628 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 6,141 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.33 (0.16 to 0.5) · 13,186 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.07 to 0.41) · 13,815 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.31 (2.04 to 4.57) · 5,254 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.07 (1.06 to 3.09) · 2,685 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.89 (0.92 to 2.86) · 4,949 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.17 (8.96 to 15.38) · 2,533 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.96 (3.13 to 6.8) · 2,632 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.78 (0.63 to 2.93) · 1,570 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.51 (0.12 to 0.91) · 11,263 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 82 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 1.048 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.372 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.731 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 267 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 17.7 · 728 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -18 · 169 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 9.6 · 408 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 13.9 · 500 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 864 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.9 to 6.5) · 877 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.4 (7.8 to 11.5) · 877 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.4 · 74 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.1 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.9 · 291 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.8) · 210 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 1,074 cases | No different | Jan 2024 – Dec 2024 |
What patients said (611 patients answered, 15% of those asked)
| Cleanliness | 1 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 1 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 58% |
| Nurses "always" communicated well | 71% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 49% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 63% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 63% |
| Staff "always" explained possible side effects | 36% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Margaret Mary Community Hospital Inc
| Clostridium Difficile (C.Diff)Infections | 2.909 | Worse | Oct 2024 – Sep 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.3 · 67 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.3 · 294 cases | None | Jul 2024 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 50 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 32.8 · 63 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 37.1 · 81 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 79 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4 to 9.1) · 104 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7 to 14.9) · 104 cases | No different | Jan 2024 – Dec 2024 |
What patients said (143 patients answered, 17% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 82% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 85% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 80% |
| Doctors "always" listened carefully | 85% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 92% |
Original Medicare doctor bills
$79,759
Medicare paid this office $79,759 for 347 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 105 | $14,197 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $9,408 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $7,915 | $106 |
| Long return visit (40+ min) | 44 | $7,383 | $148 |
| New patient visit (60+ min) | 39 | $7,173 | $184 |
See all 12 services
| Return visit (30+ min) | 105 | $14,197 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $9,408 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $7,915 | $106 |
| Long return visit (40+ min) | 44 | $7,383 | $148 |
| New patient visit (60+ min) | 39 | $7,173 | $184 |
| New patient visit (45+ min) | 59 | $7,016 | $119 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $4,618 | $154 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 16 | $3,755 | $235 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,885 | $115 |
| Measurement of liver stiffness | 94 | $1,426 | $14 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,359 | $105 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,253 | $96 |
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 16 | More than 47% of doctors who do this |
Who their Medicare patients are
347 Original Medicare patients in 2024. Average age 70 · Under 65 15% · 85 and older 6% · Women 56% · Also on Medicaid 38% · Health risk score 2.25. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 44% · Chronic kidney disease 38% · Coronary heart disease 34% · Heart failure 25% · Atrial fibrillation 22% · Depression 22% · Cancer 18% · COPD 14% · Stroke 8% · Dementia 7%.
The office billed $470,369, Medicare allowed $104,659 and paid $79,759; for 792 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 347 | 792 | 70 | 2.25 | $470,369 | $79,759 |
| 2023 | 264 | 411 | 69 | 2.09 | $183,051 | $35,635 |
| 2022 | 220 | 389 | 66 | 2.13 | $87,091 | $27,038 |
| 2021 | 229 | 461 | 67 | 2.14 | $101,747 | $33,171 |
| 2020 | 355 | 648 | 65 | 2.58 | $128,541 | $36,115 |
| 2019 | 309 | 531 | 64 | 2.36 | $120,462 | $32,800 |
| 2018 | 256 | 556 | 65 | 2.48 | $144,113 | $38,184 |
| 2017 | 253 | 578 | 64 | 2.64 | $145,493 | $43,098 |
| 2016 | 195 | 519 | 65 | 2.51 | $117,644 | $36,153 |
| 2015 | 226 | 489 | 66 | 2.36 | $165,098 | $39,324 |
| 2014 | 286 | 728 | 67 | 2.27 | $221,629 | $60,167 |
| 2013 | 246 | 631 | 65 | 2.13 | $208,900 | $51,218 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Return visit (30+ min) | 71 | $4,407 | $56 |
| New patient visit (45+ min) | 30 | $4,380 | $146 |
| Return visit (30+ min) | 39 | $4,053 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $2,766 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,746 | $65 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,551 | $232 |
| Long return visit (40+ min) | 12 | $2,055 | $158 |
| Short return visit (20+ min) | 12 | $949 | $73 |
| Short return visit (20+ min) | 19 | $688 | $36 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $468 | $39 |
| Telehealth originating site facility fee | 18 | $449 | $22 |
| Measurement of liver stiffness | 23 | $217 | $9 |
2022: 8 services
| Return visit (30+ min) | 114 | $10,071 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $4,060 | $51 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $3,844 | $148 |
| New patient visit (45+ min) | 23 | $2,003 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,838 | $74 |
| Long return visit (40+ min) | 15 | $1,754 | $110 |
| Short return visit (20+ min) | 18 | $866 | $43 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $498 | $28 |
2021: 7 services
| Return visit (30+ min) | 128 | $11,966 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $5,086 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $4,851 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $4,190 | $54 |
| New patient visit (45+ min) | 25 | $2,320 | $93 |
| Short return visit (20+ min) | 28 | $1,236 | $40 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $408 | $29 |
2020: 11 services
| Return visit (30+ min) | 142 | $10,441 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $4,078 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,903 | $156 |
| Short return visit (20+ min) | 77 | $3,321 | $35 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,900 | $81 |
| New patient visit (45+ min) | 26 | $2,039 | $78 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $1,215 | $58 |
| Telephone medical discussion with physician, 11-20 minutes | 31 | $1,194 | $36 |
| New patient visit (30+ min) | 21 | $1,110 | $53 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 25 | $1,090 | $30 |
| Return visit (30+ min) | 20 | $871 | $40 |
2019: 10 services
| Return visit (30+ min) | 130 | $9,284 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $3,713 | $77 |
| New patient visit (45+ min) | 44 | $3,681 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $3,474 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,051 | $153 |
| Short return visit (20+ min) | 66 | $2,621 | $36 |
| Return visit (30+ min) | 17 | $1,536 | $57 |
| Long return visit (40+ min) | 13 | $953 | $73 |
| New patient visit (30+ min) | 14 | $797 | $57 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $593 | $30 |
2018: 10 services
| Return visit (30+ min) | 123 | $9,307 | $51 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $6,285 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $5,201 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $3,790 | $79 |
| Long return visit (40+ min) | 22 | $2,052 | $79 |
| Return visit (30+ min) | 21 | $1,849 | $60 |
| New patient visit (45+ min) | 18 | $1,749 | $97 |
| New patient visit (60+ min) | 15 | $1,563 | $104 |
| Short return visit (20+ min) | 21 | $778 | $34 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $716 | $29 |
2017: 10 services
| Return visit (30+ min) | 95 | $7,476 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $7,366 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $6,296 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $4,828 | $55 |
| New patient visit (45+ min) | 36 | $3,276 | $91 |
| Return visit (30+ min) | 24 | $2,502 | $69 |
| Hospital discharge day management, more than 30 minutes | 21 | $1,713 | $82 |
| Long return visit (40+ min) | 16 | $1,432 | $84 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $803 | $30 |
| Short return visit (20+ min) | 13 | $488 | $33 |
2016: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 52 | $7,491 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $6,917 | $154 |
| Return visit (30+ min) | 64 | $5,136 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $4,790 | $67 |
| Return visit (30+ min) | 21 | $2,316 | $72 |
| New patient visit (45+ min) | 22 | $2,066 | $94 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 24 | $1,344 | $30 |
2015: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 25 | $5,740 | $230 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,036 | $153 |
| Return visit (30+ min) | 32 | $3,523 | $72 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $3,324 | $54 |
| Return visit (30+ min) | 45 | $3,252 | $49 |
| Biopsy of large bowel using a flexible endoscope | 18 | $2,511 | $140 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 37 | $2,236 | $29 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,198 | $78 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $1,548 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,338 | $103 |
| New patient visit (45+ min) | 15 | $1,097 | $73 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $999 | $91 |
| Short return visit (20+ min) | 18 | $908 | $50 |
2014: 14 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $9,609 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $7,135 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $6,516 | $77 |
| Return visit (30+ min) | 47 | $6,026 | $78 |
| Return visit (30+ min) | 44 | $4,521 | $57 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 17 | $3,949 | $232 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,658 | $204 |
| Biopsy of large bowel using a flexible endoscope | 16 | $2,523 | $158 |
| Short return visit (20+ min) | 34 | $2,370 | $54 |
| New patient visit (45+ min) | 18 | $2,224 | $124 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $1,974 | $76 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 44 | $1,710 | $29 |
| New patient visit (45+ min) | 12 | $1,185 | $99 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,145 | $104 |
2013: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 27 | $6,012 | $223 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $5,537 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $4,790 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $4,008 | $77 |
| Return visit (30+ min) | 27 | $3,332 | $74 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $3,078 | $88 |
| Short return visit (20+ min) | 35 | $2,892 | $53 |
| Return visit (30+ min) | 28 | $2,853 | $54 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 42 | $2,693 | $29 |
| Biopsy of large bowel using a flexible endoscope | 15 | $2,272 | $151 |
| New patient visit (45+ min) | 16 | $1,961 | $123 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,706 | $155 |
| Short return visit (20+ min) | 16 | $637 | $37 |
Medicaid work
$5,782 in 2024
Medicaid paid $5,782 for 192 billed services this clinician did in 2024, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 136 | $3,760 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 56 | $2,022 |
| 2024 | 192 | 2 | 27 | $5,782 |
| 2023 | 758 | 11 | 38 | $38,077 |
| 2022 | 959 | 10 | 26 | $37,098 |
| 2021 | 812 | 12 | 38 | $59,400 |
| 2020 | 1,236 | 15 | 51 | $83,466 |
| 2019 | 1,065 | 10 | 45 | $34,211 |
| 2018 | 912 | 7 | 30 | $5,895 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 161 | $16,710 |
| Short return visit (20+ min) | 129 | $10,580 |
| 1ST HOSP IP/OBS HIGH 75 | 30 | $4,453 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 21 | $2,497 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 26 | $1,979 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 104 | $551 |
| COMPREHENSIVE METABOLIC PANEL | 71 | $481 |
| ALPHA-FETOPROTEIN SERUM | 31 | $319 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 99 | $268 |
| Measurement of direct bilirubin | 51 | $153 |
| PROTHROMBIN TIME | 35 | $87 |
2022
| Return visit (30+ min) | 222 | $24,113 |
| Short return visit (20+ min) | 59 | $4,555 |
| 1ST HOSP IP/OBS HIGH 75 | 20 | $3,724 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 32 | $2,278 |
| COMPREHENSIVE METABOLIC PANEL | 139 | $809 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 213 | $407 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 85 | $395 |
| ALPHA-FETOPROTEIN SERUM | 29 | $357 |
| Measurement of direct bilirubin | 86 | $282 |
| PROTHROMBIN TIME | 74 | $177 |
2021
| Return visit (30+ min) | 258 | $27,204 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 87 | $8,638 |
| 1ST HOSP IP/OBS HIGH 75 | 39 | $7,568 |
| Liver elastography, mechanically induced shear wave (eg, vibration), without imaging, with interpretation and report | 14 | $5,366 |
| Short return visit (20+ min) | 67 | $5,010 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 75 | $4,360 |
| COMPREHENSIVE METABOLIC PANEL | 49 | $348 |
| ALPHA-FETOPROTEIN SERUM | 26 | $298 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 46 | $250 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 88 | $176 |
| Measurement of direct bilirubin | 36 | $119 |
| PROTHROMBIN TIME | 27 | $64 |
2020
| Return visit (30+ min) | 372 | $35,144 |
| Short return visit (20+ min) | 408 | $26,593 |
| 1ST HOSP IP/OBS HIGH 75 | 35 | $5,859 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 96 | $5,822 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 40 | $4,416 |
| New patient visit (30+ min) | 52 | $3,991 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 20 | $637 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 28 | $260 |
| ALPHA-FETOPROTEIN SERUM | 16 | $159 |
| COMPREHENSIVE METABOLIC PANEL | 24 | $157 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 24 | $116 |
| Measurement of direct bilirubin | 35 | $104 |
2019
| Return visit (30+ min) | 242 | $21,043 |
| Short return visit (20+ min) | 184 | $8,357 |
| New patient visit (30+ min) | 29 | $2,208 |
| COMPREHENSIVE METABOLIC PANEL | 115 | $824 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 119 | $607 |
| PROTHROMBIN TIME | 133 | $373 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 168 | $362 |
| Measurement of direct bilirubin | 48 | $195 |
| ALPHA-FETOPROTEIN SERUM | 14 | $146 |
| Hepatitis B surface antibody (HBsAb) | 13 | $96 |
2018
| Return visit (30+ min) | 98 | $4,151 |
| COMPREHENSIVE METABOLIC PANEL | 139 | $516 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 132 | $365 |
| PROTHROMBIN TIME | 199 | $284 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 272 | $247 |
| ALPHA-FETOPROTEIN SERUM | 32 | $242 |
| Measurement of direct bilirubin | 40 | $90 |
Drugs they prescribed that Part D paid
$223,122
Pharmacies billed $223,122 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 328) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
257 generic and 71 brand-name prescriptions · $223,122 in drug cost · 26 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xifaxan | 16 | $56,128 | $3,508 |
| Ozempic | 16 | $15,166 | $948 |
| Tenofovir Disoproxil | 28 | $9,274 | $331 |
| Ursodiol | 32 | $5,084 | $159 |
| Entecavir | 14 | $1,247 | $89 |
See all 13 drugs
| Xifaxan | 16 | $56,128 | $3,508 |
| Ozempic | 16 | $15,166 | $948 |
| Tenofovir Disoproxil | 28 | $9,274 | $331 |
| Ursodiol | 32 | $5,084 | $159 |
| Entecavir | 14 | $1,247 | $89 |
| Peg 3350-Electrolyte | 30 | $645 | $22 |
| Lactulose | 16 | $588 | $37 |
| Mycophenolate Mofetil | 11 | $441 | $40 |
| Amiloride | 18 | $179 | $10 |
| Spironolactone | 15 | $150 | $10 |
| Furosemide | 19 | $102 | $5 |
| Pantoprazole | 11 | $44 | $4 |
| Carvedilol | 13 | $41 | $3 |
Year by year
| 2024 | 328 | 126 | 0% (0) | 22% | $223,122 |
| 2023 | 734 | 121 | None | None | $365,400 |
| 2022 | 981 | 112 | None | 25% | $585,845 |
| 2021 | 974 | 111 | 1% (11) | 28% | $621,437 |
| 2020 | 1,049 | 121 | 1% (11) | 27% | $758,258 |
| 2019 | 899 | 125 | 2% (16) | 26% | $580,837 |
| 2018 | 872 | 113 | 2% (15) | 27% | $795,342 |
| 2017 | 796 | 127 | 2% (17) | 36% | $1,613,378 |
| 2016 | 744 | 101 | 2% (17) | 38% | $1,668,884 |
| 2015 | 752 | 109 | 9% (67) | 39% | $1,380,481 |
| 2014 | 799 | 124 | 11% (85) | 36% | $1,373,187 |
| 2013 | 523 | 125 | 8% (40) | None | $165,640 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Xifaxan | 77 | $254,268 | $3,302 |
| Ozempic | 13 | $26,777 | $2,060 |
| Ursodiol | 53 | $15,254 | $288 |
| Lubiprostone | 25 | $9,270 | $371 |
| Linzess | 11 | $9,060 | $824 |
| Entecavir | 11 | $7,249 | $659 |
| Lactulose | 39 | $2,882 | $74 |
| Azathioprine | 31 | $2,364 | $76 |
| Budesonide Dr | 12 | $1,785 | $149 |
| Esomeprazole Magnesium | 13 | $1,352 | $104 |
| Spironolactone | 75 | $1,157 | $15 |
| Prevalite | 12 | $1,156 | $96 |
| Tacrolimus | 11 | $1,083 | $98 |
| Ondansetron Odt | 14 | $956 | $68 |
| Furosemide | 93 | $480 | $5 |
| Metronidazole | 11 | $428 | $39 |
| Pantoprazole | 14 | $379 | $27 |
| Peg 3350-Electrolyte | 11 | $292 | $27 |
| Topiramate | 21 | $275 | $13 |
| Constulose | 12 | $234 | $20 |
| Atorvastatin | 11 | $201 | $18 |
| Carvedilol | 27 | $165 | $6 |
| Prednisone | 14 | $73 | $5 |
2022: 23 drugs
| Xifaxan | 117 | $366,790 | $3,135 |
| Ozempic | 18 | $27,763 | $1,542 |
| Lubiprostone | 37 | $25,185 | $681 |
| Ursodiol | 80 | $24,438 | $305 |
| Linzess | 14 | $10,810 | $772 |
| Lactulose | 40 | $3,053 | $76 |
| Spironolactone | 129 | $2,362 | $18 |
| Budesonide Ec | 15 | $1,734 | $116 |
| Azathioprine | 37 | $1,659 | $45 |
| Budesonide Dr | 14 | $1,229 | $88 |
| Metronidazole | 17 | $648 | $38 |
| Furosemide | 99 | $562 | $6 |
| Pantoprazole | 16 | $552 | $35 |
| Tacrolimus | 13 | $470 | $36 |
| Dextroamphetamine-Amphetamine | 15 | $308 | $21 |
| Omeprazole | 28 | $295 | $11 |
| Prednisone | 36 | $263 | $7 |
| Topiramate | 20 | $256 | $13 |
| Famotidine | 11 | $255 | $23 |
| Carvedilol | 20 | $116 | $6 |
| Trazodone | 11 | $49 | $4 |
| Zolpidem | 13 | $23 | $2 |
| Gabapentin | 11 | $23 | $2 |
2021: 24 drugs
| Xifaxan | 133 | $373,434 | $2,808 |
| Ursodiol | 94 | $22,987 | $245 |
| Lubiprostone | 23 | $11,496 | $500 |
| Amitiza | 23 | $10,579 | $460 |
| Spironolactone | 96 | $2,019 | $21 |
| Azathioprine | 32 | $1,812 | $57 |
| Budesonide Ec | 16 | $1,732 | $108 |
| Ondansetron Odt | 16 | $1,048 | $65 |
| Pantoprazole | 35 | $989 | $28 |
| Lactulose | 23 | $797 | $35 |
| Metronidazole | 24 | $791 | $33 |
| Omeprazole | 30 | $743 | $25 |
| Dextroamphetamine-Amphetamine | 22 | $432 | $20 |
| Furosemide | 71 | $403 | $6 |
| Mycophenolate Mofetil | 11 | $361 | $33 |
| Topiramate | 27 | $322 | $12 |
| Prednisone | 31 | $276 | $9 |
| Hydrocodone-Acetaminophen | 11 | $217 | $20 |
| Carvedilol | 18 | $208 | $12 |
| Atorvastatin | 18 | $180 | $10 |
| Potassium Chloride | 12 | $154 | $13 |
| Gabapentin | 27 | $85 | $3 |
| Ciprofloxacin | 13 | $52 | $4 |
| Zolpidem | 15 | $50 | $3 |
2020: 26 drugs
| Xifaxan | 142 | $381,705 | $2,688 |
| Ocaliva | 11 | $84,909 | $7,719 |
| Ursodiol | 89 | $25,607 | $288 |
| Amitiza | 48 | $22,841 | $476 |
| Lactulose | 38 | $2,277 | $60 |
| Spironolactone | 101 | $2,097 | $21 |
| Entecavir | 14 | $1,267 | $90 |
| Metronidazole | 39 | $1,222 | $31 |
| Budesonide Ec | 12 | $863 | $72 |
| Furosemide | 76 | $730 | $10 |
| Amiloride | 17 | $629 | $37 |
| Gabapentin | 38 | $582 | $15 |
| Potassium Chloride | 26 | $551 | $21 |
| Omeprazole | 26 | $525 | $20 |
| Dextroamphetamine-Amphetamine | 22 | $523 | $24 |
| Pantoprazole | 33 | $422 | $13 |
| Azathioprine | 15 | $399 | $27 |
| Topiramate | 39 | $396 | $10 |
| Hydrocodone-Acetaminophen | 11 | $323 | $29 |
| Carvedilol | 22 | $216 | $10 |
| Ciprofloxacin | 12 | $168 | $14 |
| Prednisone | 19 | $150 | $8 |
| Mycophenolate Mofetil | 11 | $133 | $12 |
| Nortriptyline | 13 | $116 | $9 |
| Trazodone | 13 | $67 | $5 |
| Zolpidem | 23 | $56 | $2 |
2019: 24 drugs
| Xifaxan | 95 | $218,538 | $2,300 |
| Ocaliva | 21 | $70,207 | $3,343 |
| Ursodiol | 91 | $25,473 | $280 |
| Amitiza | 21 | $12,342 | $588 |
| Budesonide Ec | 16 | $4,957 | $310 |
| Entecavir | 29 | $2,337 | $81 |
| Spironolactone | 72 | $1,676 | $23 |
| Metronidazole | 41 | $996 | $24 |
| Lactulose | 29 | $753 | $26 |
| Azathioprine | 22 | $667 | $30 |
| Dextroamphetamine-Amphetamine | 23 | $544 | $24 |
| Furosemide | 61 | $527 | $9 |
| Amiloride | 16 | $526 | $33 |
| Pantoprazole | 17 | $495 | $29 |
| Gabapentin | 23 | $406 | $18 |
| Ciprofloxacin | 39 | $405 | $10 |
| Hydrocodone-Acetaminophen | 12 | $326 | $27 |
| Prednisone | 34 | $249 | $7 |
| Carvedilol | 26 | $247 | $9 |
| Topiramate | 26 | $232 | $9 |
| Zolpidem | 24 | $197 | $8 |
| Potassium Chloride | 13 | $181 | $14 |
| Omeprazole | 23 | $141 | $6 |
| Trazodone | 13 | $66 | $5 |
2018: 23 drugs
| Xifaxan | 39 | $102,917 | $2,639 |
| Ocaliva | 26 | $78,173 | $3,007 |
| Ursodiol | 66 | $19,531 | $296 |
| Entecavir | 47 | $15,150 | $322 |
| Amitiza | 24 | $12,816 | $534 |
| Prevacid | 15 | $3,125 | $208 |
| Metronidazole | 54 | $1,460 | $27 |
| Azathioprine | 19 | $1,210 | $64 |
| Spironolactone | 75 | $1,114 | $15 |
| Amiloride | 20 | $663 | $33 |
| Lactulose | 14 | $562 | $40 |
| Dextroamphetamine-Amphetamine | 24 | $559 | $23 |
| Furosemide | 86 | $367 | $4 |
| Hydrocodone-Acetaminophen | 13 | $352 | $27 |
| Generlac | 12 | $323 | $27 |
| Pantoprazole | 17 | $289 | $17 |
| Prednisone | 41 | $247 | $6 |
| Omeprazole | 35 | $213 | $6 |
| Gabapentin | 11 | $202 | $18 |
| Topiramate | 18 | $168 | $9 |
| Carvedilol | 27 | $134 | $5 |
| Ciprofloxacin | 11 | $129 | $12 |
| Zolpidem | 15 | $72 | $5 |
2017: 22 drugs
| Harvoni | 27 | $852,326 | $31,568 |
| Xifaxan | 62 | $135,056 | $2,178 |
| Ursodiol | 34 | $12,287 | $361 |
| Amitiza | 19 | $10,864 | $572 |
| Prevacid | 25 | $5,203 | $208 |
| Entecavir | 12 | $4,458 | $371 |
| Spironolactone | 73 | $1,051 | $14 |
| Amiloride | 21 | $912 | $43 |
| Azathioprine | 11 | $705 | $64 |
| Dextroamphetamine-Amphetamine | 24 | $617 | $26 |
| Lactulose | 17 | $446 | $26 |
| Hydrocodone-Acetaminophen | 13 | $399 | $31 |
| Metronidazole | 19 | $380 | $20 |
| Furosemide | 84 | $331 | $4 |
| Omeprazole | 46 | $296 | $6 |
| Polyethylene Glycol 3350 | 15 | $239 | $16 |
| Propranolol | 15 | $215 | $14 |
| Pantoprazole | 16 | $132 | $8 |
| Prednisone | 20 | $103 | $5 |
| Topiramate | 17 | $98 | $6 |
| Carvedilol | 18 | $77 | $4 |
| Zolpidem | 13 | $50 | $4 |
2016: 20 drugs
| Harvoni | 29 | $916,563 | $31,606 |
| Xifaxan | 49 | $102,825 | $2,098 |
| Creon | 14 | $23,508 | $1,679 |
| Ursodiol | 44 | $14,828 | $337 |
| Apriso | 22 | $9,297 | $423 |
| Prevacid | 23 | $4,530 | $197 |
| Ribavirin | 18 | $3,199 | $178 |
| Amiloride | 13 | $891 | $69 |
| Spironolactone | 49 | $872 | $18 |
| Lactulose | 25 | $679 | $27 |
| Azathioprine | 15 | $635 | $42 |
| Dextroamphetamine-Amphetamine | 24 | $593 | $25 |
| Hydrocodone-Acetaminophen | 14 | $521 | $37 |
| Ciprofloxacin | 15 | $484 | $32 |
| Omeprazole | 54 | $457 | $8 |
| Furosemide | 61 | $337 | $6 |
| Zolpidem | 22 | $180 | $8 |
| Pantoprazole | 19 | $139 | $7 |
| Prednisone | 16 | $103 | $6 |
| Topiramate | 14 | $43 | $3 |
2015: 25 drugs
| Harvoni | 19 | $608,895 | $32,047 |
| Sovaldi | 20 | $564,047 | $28,202 |
| Xifaxan | 52 | $94,353 | $1,814 |
| Creon | 13 | $21,148 | $1,627 |
| Ursodiol | 14 | $10,447 | $746 |
| Apriso | 18 | $7,307 | $406 |
| Amitiza | 15 | $4,389 | $293 |
| Prevacid | 24 | $4,115 | $171 |
| Linzess | 12 | $3,382 | $282 |
| Welchol | 13 | $2,001 | $154 |
| Ribavirin | 16 | $1,947 | $122 |
| Nadolol | 13 | $893 | $69 |
| Moviprep | 11 | $879 | $80 |
| Spironolactone | 31 | $732 | $24 |
| Hydrocodone-Acetaminophen | 18 | $669 | $37 |
| Pantoprazole | 36 | $597 | $17 |
| Omeprazole | 60 | $557 | $9 |
| Dextroamphetamine-Amphetamine | 15 | $439 | $29 |
| Tramadol | 45 | $399 | $9 |
| Furosemide | 46 | $318 | $7 |
| Ciprofloxacin | 12 | $262 | $22 |
| Ondansetron | 15 | $225 | $15 |
| Zolpidem | 13 | $119 | $9 |
| Promethazine | 15 | $71 | $5 |
| Topiramate | 12 | $68 | $6 |
2014: 25 drugs
| Sovaldi | 27 | $765,559 | $28,354 |
| Olysio | 18 | $408,315 | $22,684 |
| Xifaxan | 40 | $60,851 | $1,521 |
| Budesonide Ec | 24 | $21,673 | $903 |
| Creon | 20 | $20,913 | $1,046 |
| Ursodiol | 19 | $8,121 | $427 |
| Opana Er | 12 | $6,705 | $559 |
| Prevacid | 24 | $3,402 | $142 |
| Welchol | 18 | $2,960 | $164 |
| Moviprep | 24 | $1,896 | $79 |
| Spironolactone | 47 | $1,179 | $25 |
| Lactulose | 18 | $645 | $36 |
| Pantoprazole | 49 | $564 | $12 |
| Oxycodone | 16 | $463 | $29 |
| Ondansetron | 15 | $449 | $30 |
| Hydrocodone-Acetaminophen | 24 | $352 | $15 |
| Omeprazole | 37 | $333 | $9 |
| Gabapentin | 22 | $295 | $13 |
| Promethazine | 35 | $163 | $5 |
| Furosemide | 33 | $157 | $5 |
| Tramadol | 26 | $144 | $6 |
| Clonazepam | 11 | $126 | $11 |
| Levothyroxine | 11 | $122 | $11 |
| Carvedilol | 12 | $108 | $9 |
| Zolpidem | 12 | $82 | $7 |
2013: 14 drugs
| Xifaxan | 15 | $21,284 | $1,419 |
| Creon | 14 | $10,607 | $758 |
| Ursodiol | 16 | $3,340 | $209 |
| Prevacid | 19 | $2,482 | $131 |
| Moviprep | 24 | $1,700 | $71 |
| Spironolactone | 41 | $1,616 | $39 |
| Ondansetron | 19 | $589 | $31 |
| Cholestyramine | 11 | $406 | $37 |
| Pantoprazole | 35 | $366 | $10 |
| Omeprazole | 31 | $284 | $9 |
| Gavilyte-N | 15 | $260 | $17 |
| Clonazepam | 14 | $212 | $15 |
| Tramadol | 13 | $171 | $13 |
| Furosemide | 23 | $107 | $5 |
Money from drug and device companies
$86 in 2025
A payment is not proof that care is biased.
| Madrigal Pharmaceuticals | Rezdiffra | $86 | 2 payments
|
See all 2 published payments
| Madrigal Pharmaceuticals | Meals · 2025-12-05 | Rezdiffra | $44 |
| Madrigal Pharmaceuticals | Meals · 2025-10-17 | Rezdiffra | $41 |
Professional record
- NPI
- 1770630162
- Licence
- CA C184254California C184254: Current · expires 2027-02-28
- Group
- Margaret Mary Community Hospital Inc · Iu Health Medical Group LLC
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- MN 440002000
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X); Federal specialty code 207RT0003X (207RT0003X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-01-05
- NPI last updated
- 2025-02-06
- NPI record certified
- 2025-02-06
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 550 University Blvd, Indianapolis, IN, 46202
This office lists an electronic records connection.